表紙:DNAナノテクノロジーの世界市場:タイプ別、用途別、エンドユーザー別、地域別、競合予測と機会、2017年~2027年
市場調査レポート
商品コード
1069628

DNAナノテクノロジーの世界市場:タイプ別、用途別、エンドユーザー別、地域別、競合予測と機会、2017年~2027年

Global DNA Nanotechnology Market, By Type, By Application, By End User, By Region, Competition Forecast and Opportunities, 2017-2027

出版日: | 発行: TechSci Research | ページ情報: 英文 117 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

DNAナノテクノロジーの世界市場:タイプ別、用途別、エンドユーザー別、地域別、競合予測と機会、2017年~2027年
出版日: 2022年04月01日
発行: TechSci Research
ページ情報: 英文 117 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のDNAナノテクノロジーの市場規模は、予測期間である2023年~2027年に著しい拡大を遂げると予測されています。

同市場の成長の背景には、ナノテクノロジーにおける進歩の高まりと、ヘルスケア分野における用途の拡大があります。製薬企業における効果的かつ効率的なドラッグデリバリーシステムに対する需要の急増と、ナノ粒子に対する市場参入企業の多額の投資が、同市場の今後の成長を促進する要因となっています。

当レポートでは、世界のDNAナノテクノロジー市場について調査し、市場の概要とともに、タイプ別、用途別、エンドユーザー別、地域別の動向、競合動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のDNAナノテクノロジー市場に対するCOVID-19の影響

第5章 顧客の声

第6章 世界のDNAナノテクノロジー市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別(構造的DNAナノテクノロジー、動的DNAナノテクノロジー)
    • 用途別(標的化ドラッグデリバリー、スマートピル、ナノリソグラフィ、その他)
    • エンドユーザー別(バイオテクノロジー企業・製薬会社、学術・研究機関、その他)
    • 企業別(2021年)
    • 地域別
  • 市場マップ

第7章 北米のDNAナノテクノロジー市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 北米:国別分析

第8章 欧州のDNAナノテクノロジー市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 欧州:国別分析

第9章 アジア太平洋のDNAナノテクノロジー市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • アジア太平洋:国別分析

第10章 南米のDNAナノテクノロジー市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 南米:国別分析

第11章 中東・アフリカのDNAナノテクノロジー市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 中東・アフリカ:国別分析

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と発展

第14章 競合情勢

  • NuProbe USA Inc.
  • tilibit nanosystems GmbH
  • GATTAquant GmbH
  • Genisphere LLC
  • Inovio Pharmaceuticals, Inc.
  • Novartis International AG

第15章 戦略的推奨事項

目次
Product Code: 8174

Global DNA nanotechnology market is projected to register growth at a significant rate during the forecast period, 2023-2027. The market growth can be attributed to the rising advancements in nanotechnology and its growing number of applications in the healthcare sector. A surge in demand for the effective and efficient drug delivery system in pharmaceutical companies and heavy investments from market players in nano particles are driving the demand for the future growth of the global DNA nanotechnology market. Nanotechnology is the branch of science and engineering that deals with designing, producing, and utilizing structures through manipulating atoms and molecules at nanoscale. Nanotechnology finds application in multiple domains of science such as organic chemistry, semiconductor physics, molecular biology, nanomedicine, nanoelectronics, etc. DNA nanotechnology can perform computation in a biocompatible format to synthesize smart drugs for targeted drug delivery. Hence, the technology is rapidly adopted by the pharmaceutical industry players, which is expected to fuel the growth of the global DNA nanotechnology market. Increasing investments from the government and private sector in the healthcare sector to support advancements in therapeutics, pharmaceutical products, medical devices, etc., are expected to drive the growth of the global DNA nanotechnology market. Furthermore, increasing incidences of chronic disorders such as cardiovascular problems, diabetes, genetic diseases, cancer, etc., are substantiating the growth of the global DNA nanotechnology market.

The global DNA nanotechnology market segmentation is based on type, application, end user, regional distribution, and competitive landscape. Based on application, the market is further divided into targeted drug delivery, smart pills, nanolithography, and others. Targeted drug delivery segment is anticipated to hold the largest share in the global DNA nanotechnology market in the coming years owing to factors such as rising demand for efficient and targeted drug delivery and growing instances of cancer across the world. However, smart pills are expected to grow at the fastest rate in the global DNA nanotechnology market owing to their rising usage for personalized medicine and nanomedicine.

Major players operating in the global DNA nanotechnology market are NuProbe USA Inc., tilibit nanosystems GmbH, GATTAquant GmbH, Genisphere LLC, Inovio Pharmaceuticals, Inc., Novartis International AG, etc.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2023-2027

Objective of the Study:

  • To analyze the historical growth in the market size of global DNA nanotechnology market from 2017 to 2021.
  • To estimate and forecast the market size of global DNA nanotechnology market from 2022 to 2027 and growth rate until 2027.
  • To classify and forecast global DNA nanotechnology market based on product type, application, fuel type, region, and competitive landscape.
  • To identify dominant region or segment in the global DNA nanotechnology market.
  • To identify drivers and challenges for global DNA nanotechnology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global DNA nanotechnology market.
  • To identify and analyze the profile of leading players operating in the global DNA nanotechnology market.
  • To identify key sustainable strategies adopted by market players in the global DNA nanotechnology market.

Report Scope:

In this report, global DNA nanotechnology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • DNA Nanotechnology Market, By Type:

Structural DNA Nanotechnology

  • Extended Lattices
  • Discrete Structures
  • Templated Assembly

Dynamic DNA Nanotechnology

  • Nanomechanical Devices
  • Strand Displacement Cascades
  • DNA Nanotechnology Market, By Application:

Targeted Drug Delivery

Smart Pills

Nanolithography

Others

  • DNA Nanotechnology Market, By End User:

Biotechnology & Pharmaceutical Companies

Academic & Research Institutions

Others

  • DNA Nanotechnology Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

South America

  • Brazil
  • Argentina
  • Colombia

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of the global DNA nanotechnology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • DNA nanotechnology service provider companies/partners
  • Suppliers/Distributers
  • End-Users
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to global DNA nanotechnology market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc. besides allowing them in strategizing investments and capitalizing on market opportunities.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global DNA nanotechnology market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global DNA Nanotechnology Market

5. Voice of Customer

  • 5.1. Factors Contributing to Switch Over to DNA Nanotechnology
  • 5.2. Barriers to Adoption of DNA Nanotechnology
  • 5.3. Brand Awareness

6. Global DNA Nanotechnology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 6.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 6.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 6.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 6.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 6.2.4. By Company (2021)
    • 6.2.5. By Region
  • 6.3. Market Map

7. North America DNA Nanotechnology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 7.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 7.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 7.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 7.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States DNA Nanotechnology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Mexico DNA Nanotechnology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Canada DNA Nanotechnology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe DNA Nanotechnology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 8.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 8.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 8.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 8.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France DNA Nanotechnology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany DNA Nanotechnology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom DNA Nanotechnology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy DNA Nanotechnology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain DNA Nanotechnology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific DNA Nanotechnology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 9.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 9.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 9.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 9.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China DNA Nanotechnology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India DNA Nanotechnology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Korea DNA Nanotechnology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. Japan DNA Nanotechnology Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia DNA Nanotechnology Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America DNA Nanotechnology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 10.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 10.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 10.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 10.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil DNA Nanotechnology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina DNA Nanotechnology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia DNA Nanotechnology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa DNA Nanotechnology Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 11.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 11.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 11.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 11.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 11.2.4. By Country
  • 11.3. Middle east and Africa: Country Analysis
    • 11.3.1. South Africa DNA Nanotechnology Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia DNA Nanotechnology Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE DNA Nanotechnology Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User
    • 11.3.4. Egypt DNA Nanotechnology Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type
        • 11.3.4.2.2. By Application
        • 11.3.4.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends and Developments

14. Competitive Landscape

  • 14.1. NuProbe USA Inc.
  • 14.2. tilibit nanosystems GmbH
  • 14.3. GATTAquant GmbH
  • 14.4. Genisphere LLC
  • 14.5. Inovio Pharmaceuticals, Inc.
  • 14.6. Novartis International AG

15. Strategic Recommendations